tyramine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z | 1 |
| Lan, X | 1 |
| Wu, D | 1 |
| Sunkel, B | 1 |
| Ye, Z | 1 |
| Huang, J | 1 |
| Liu, Z | 1 |
| Clinton, SK | 1 |
| Jin, VX | 1 |
| Wang, Q | 1 |
1 other study available for tyramine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
Topics: Acetates; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Chro | 2015 |